文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌局灶挽救性HDR近距离放疗后的复发特征

Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer.
PubMed 文献 · Radiother Oncol · 2023-01-25

本研究前瞻性纳入2013年7月至2021年10月接受MRI引导单次19 Gy局灶挽救性HDR近距离放疗的175例放射性复发前列腺癌患者,中位随访36个月。3年生化无复发生存率为43%,局部无复发生存率为51%,野内局部无复发生存率为70%,野内复发与较大GTV尺寸和较短PSA倍增时间相关;后续复发大多为局部和野内复发。

要点

  • 局灶挽救性HDR近距离放疗(1×19 Gy)后3年生化无复发生存率为43%。
  • 3年局部无复发生存率为51%,野内局部无复发生存率为70%。
  • 较大GTV尺寸和较短PSA倍增时间与野内局部复发相关。

核心结论

  • 局灶挽救性HDR近距离放疗(剂量1×19 Gy)治疗局部前列腺癌复发后,后续复发大多为局部和野内复发。

研究设计与样本

  • 前瞻性纳入2013年7月至2021年10月接受MRI引导单次19 Gy局灶挽救性HDR近距离放疗的患者,共175例,中位随访36个月(IQR 23-50)。

主要发现

  • 3年生化无复发生存率为43%(95%CI 34%-52%),局部无复发生存率为51%(41%-61%),野内局部无复发生存率为70%(61%-80%)。
  • 3年野外局部无复发生存率为92%(88%-97%),任何无复发生存率为42%(32%-52%),无ADT生存率为86%(80%-92%)。
  • 多变量分析中,较大GTV尺寸和较短PSA倍增时间与野内局部复发相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiorecurrent prostate cancer is often confined to the prostate, predominantly near the index lesion. The purpose of this study was to look at recurrence characteristics in patients treated with focal salvage high dose-rate (HDR) brachytherapy. MATERIALS AND METHODS: Patients treated with MRI-guided HDR brachytherapy, with a single fraction of 19 Gy from July 2013 to October 2021 as focal salvage treatment, were prospectively included in the current study. Imaging data were collected regarding the occurrence of local, regional and distant recurrences, including location of local recurrences (LR) in relation to the HDR radiotherapy field. RESULTS: One hundred seventy-five patients were included after focal salvage HDR brachytherapy (median follow-up 36 months (IQR 23-50)). Three-years biochemical recurrence-free survival, LR-free survival, in-field LR-free survival, out-of-field LR-free survival, any-recurrence-free survival and ADT-free survival were 43% (95%CI 34%-52%), 51% (41%-61%), 70% (61%-80%), 92% (88%-97%), 42% (32%-52%) and 86% (80%-92%), respectively. Larger GTV-size and shorter PSA doubling time were associated with in-field LR in multivariable analysis. CONCLUSION: After focal salvage HDR brachytherapy with a dose of 1x19 Gy for local prostate cancer recurrence, subsequent recurrences are mostly local and in-field.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Rasing MJA, Peters M, van Son M, et al. Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer. Radiother Oncol. 2023. PMID: 36708924. doi:10.1016/j.radonc.2023.109495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。